Skip to main content
Clinical Trials/CTRI/2024/04/065246
CTRI/2024/04/065246
Not yet recruiting
Phase 3

Development standardization and clinical evaluation of Punarnava Arka in Dry Eye Syndrome w.s.r.t. Shushkakshipaka- Randomized Controlled Clinical Trial - NI

KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur, BELAGAVI0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: H048- Other disorders of lacrimal system
Sponsor
KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur, BELAGAVI
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
KAHERs Shri BMK Ayurveda Mahavidyalaya Shahapur, BELAGAVI

Eligibility Criteria

Inclusion Criteria

  • 1 Clinical features of DES with reduced quantity and stability of Tear Fluid
  • 2 Age of 18 to 40 years and of either genders

Exclusion Criteria

  • Severe conditions like Steven Johnsons syndrome Chemical Thermal Radiation burns idiopathic atrophy Trachoma Ocular pemphigoid
  • Corneal epitheliopathies like Neuroparalytic keratitis post herpatic post measles infection of cornea
  • Conjunctival epitheliopathies like Pterygium Pseudo pterygium Tumours Retention cysts chronic low grade bacterial viral conjunctivitis
  • Lid abnormalities like Meibominitis Blepharitits Facial nerve palsy Lagophthalmous
  • Lacrimal gland diseases like infiltration of gland with sarcoidosis lymphoma leukemia and amyloidosis congenital Alacrima
  • Vitamin A deficiency effect of the drugs like atropine antihistamine diuretics
  • Specific systemic infections like Tuberculosis Leprosy Hypertension RA Diabetes mellitus etc

Outcomes

Primary Outcomes

Not specified

Similar Trials